Urothelial Bladder Cancer — Microlearning Activity 1 with Dr Terence Friedlander: ESMO Congress 2025 Review
About this episode
Dr. Terence Friedlander discusses therapy selection for bladder cancer and reviews findings from the 2025 ESMO Congress.
Dr Terence Friedlander discusses the selection and sequencing of therapy for patients with bladder cancer and reviews clinical findings recently presented at the 2025 ESMO Congress. CME information and select publications here .
More episodes of Prostate Cancer Update
- Prostate Cancer — Year in Review Series on Relevant New Datasets and Advances
- Metastatic Bladder Cancer — Rapid Case Review Issue 4
- AKT Inhibition in Prostate Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers Symposium
- Metastatic Bladder Cancer — Rapid Case Review Issue 3
- Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Proceedings from a Session Held Adjunct to the 2026 ASCO Genitourinary Cancers Symposium
- Urothelial Bladder Cancer — Microlearning Activity 2 with Dr Terence Friedlander: ESMO Congress 2025 Review
Explore listener stats, chart rankings, contacts and more on the Prostate Cancer Update podcast page.